Targeting osteoblast-specific transcription factor: A common approach for ankylosing spondylitis and the tumor microenvironment

Int J Rheum Dis. 2024 Mar;27(3):e15117. doi: 10.1111/1756-185X.15117.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Osteoblasts / pathology
  • Spondylitis, Ankylosing* / diagnosis
  • Spondylitis, Ankylosing* / drug therapy
  • Spondylitis, Ankylosing* / pathology
  • Tumor Microenvironment
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha